title: Scavenger receptors may regulate nitric oxide production from macrophages stimulated by LPS.
abstract: The effects of scavenger receptor (SR) ligands on nitric oxide (NO) production were investigated using mouse peritoneal macrophages stimulated by LPS. Pretreatment of macrophages with oxidized LDL, heparin, maleylated BSA, or liposomes composed of phosphatidylserine (PS-liposomes) inhibited NO production, but native LDL, acetyl LDL dextran sulfate, did not. Immunoblotting analysis suggests that the inhibitory effects could be a result of the inhibition of inducible NO synthase (iNOS) induction, but not enzyme activity. Further, tyrosine phosphorylation of a 41 kDa protein was also inhibited by OxLDL, heparin, maleylated BSA, and PS-liposomes. Chloroquine did not affect the extent of inhibition of NO production induced by these ligands, suggesting that the binding of these ligands to SR generates a signal(s) which is involved in the inhibition of NO production from macrophages stimulated by LPS. SR, which has an affinity to these ligands, may strictly regulate NO production from macrophages, and this inhibitory effect may be due to the inhibition of LPS-induced tyrosine phosphorylation of 41 kDa protein.
authors.affiliation: School of Pharmacy, Tokyo University of Pharmacy and Life Science, Japan.
authors.forename: R
authors.initials: R
authors.lastname: Matsuno
authors.forename: Y
authors.initials: Y
authors.lastname: Aramaki
authors.forename: H
authors.initials: H
authors.lastname: Arima
authors.forename: S
authors.initials: S
authors.lastname: Tsuchiya
mesh_terms: D000818:Animals; D002478:Cells, Cultured; D002738:Chloroquine / Q000494:pharmacology; D006493:Heparin / Q000494:pharmacology; D008070:Lipopolysaccharides / Q000494:pharmacology*; D008077:Lipoproteins, LDL / Q000494:pharmacology; D008247:Lysosomes / Q000187:drug effects / Q000502:physiology; D017737:Macrophages, Peritoneal / Q000187:drug effects / Q000502:physiology*; D008297:Male; D008298:Maleates / Q000494:pharmacology; D008565:Membrane Proteins; D051379:Mice; D008809:Mice, Inbred C3H; D009569:Nitric Oxide / Q000096:biosynthesis*; D019001:Nitric Oxide Synthase / Q000096:biosynthesis*; D009573:Nitrites / Q000032:analysis; D010718:Phosphatidylserines; D010766:Phosphorylation; D019000:Phosphotyrosine / Q000378:metabolism; D011971:Receptors, Immunologic / Q000187:drug effects / Q000502:physiology*; D018110:Receptors, Lipoprotein; D051116:Receptors, Scavenger; D051122:Scavenger Receptors, Class B; D012710:Serum Albumin, Bovine / Q000494:pharmacology
chemical_list: D008070:Lipopolysaccharides; D008077:Lipoproteins, LDL; D008298:Maleates; D008565:Membrane Proteins; D009573:Nitrites; D010718:Phosphatidylserines; D011971:Receptors, Immunologic; D018110:Receptors, Lipoprotein; D051116:Receptors, Scavenger; C454739:Scarb1 protein, mouse; D051122:Scavenger Receptors, Class B; C049877:maleylalbumin; C099252:oxidized low density lipoprotein; D019000:Phosphotyrosine; D012710:Serum Albumin, Bovine; D009569:Nitric Oxide; D002738:Chloroquine; D006493:Heparin; D019001:Nitric Oxide Synthase